The Cooper Companies, Inc. $COO Shares Sold by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 23.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,250 shares of the medical device company’s stock after selling 11,710 shares during the period. Motley Fool Asset Management LLC’s holdings in Cooper Companies were worth $2,793,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in COO. Zions Bancorporation National Association UT acquired a new position in Cooper Companies during the first quarter valued at $33,000. J.Safra Asset Management Corp lifted its position in Cooper Companies by 204.8% during the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 340 shares during the period. GKV Capital Management Co. Inc. acquired a new position in Cooper Companies during the first quarter valued at $40,000. Larson Financial Group LLC raised its position in shares of Cooper Companies by 1,071.0% in the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock worth $61,000 after acquiring an additional 664 shares during the period. Finally, HM Payson & Co. raised its position in shares of Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company’s stock worth $75,000 after acquiring an additional 532 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Albert G. White III purchased 10,000 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The stock was purchased at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the transaction, the chief executive officer directly owned 226,151 shares in the company, valued at approximately $15,466,466.89. This trade represents a 4.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Brian G. Andrews purchased 1,525 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 2nd. The shares were bought at an average price of $65.68 per share, with a total value of $100,162.00. Following the transaction, the executive vice president owned 22,191 shares in the company, valued at approximately $1,457,504.88. The trade was a 7.38% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have acquired 17,975 shares of company stock worth $1,216,346. Company insiders own 1.98% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on COO. BNP Paribas upgraded shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cooper Companies in a research report on Wednesday, October 8th. Mizuho decreased their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, July 16th. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 price objective on shares of Cooper Companies in a research report on Thursday, August 28th. Finally, Wall Street Zen downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $84.77.

Cooper Companies Stock Down 1.5%

COO opened at $71.75 on Wednesday. The Cooper Companies, Inc. has a twelve month low of $61.78 and a twelve month high of $107.84. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The company has a 50-day moving average price of $69.61 and a 200 day moving average price of $73.16. The company has a market cap of $14.26 billion, a PE ratio of 35.35, a price-to-earnings-growth ratio of 1.91 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the firm earned $0.96 EPS. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical device company to buy up to 15.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s management believes its shares are undervalued.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.